On February 23, 2023, Jamieson Wellness Inc. partnered with DCP Capital, a private equity firm specialized in Greater China and Asian markets. DCP acquired a minority interest in Jamieson's Chinese operations for approximately $47.4 million (or $35 million USD), gaining a 33.3% stake. Additionally, DCP invested around $101.6 million (or $75 million USD) in preferred shares of Jamieson Wellness and subscribed for warrants to purchase 2,527,121 common shares at a premium price. This partnership aims to boost Jamieson's growth in China's vast vitamins, minerals, and supplements market, leveraging the company's high-quality products and DCP's local market expertise.

The completion of these transactions, expected in the second quarter of 2023, depends on the acquisition of assets from Jamieson's Chinese distributor and regulatory approvals. Nomura Securities International, Inc., McCarthy Tétrault LLP, and Morrison & Foerster LLP served as financial and legal advisors to Jamieson Wellness. CG/Sawaya Partners (under Canaccord Genuity), Solomon Partners, Cleary Gottlieb Steen & Hamilton LLP, and Stikeman Elliott LLP advised DCP.